Research Paper Volume 16, Issue 2 pp 1712—1732
Malignant cell receptor-ligand subtypes guide the prediction of prognosis and personalized immunotherapy of liver cancer
Figure 8. RiskScore in different clinicopathological features. (A) Comparison of clinical phenotypes between RiskScore groups in the TCGA cohort. (B) Differences between RiskScores of different phenotypes in the TCGA cohort (Wilcox. Test, *P < 0.05; **P < 0.01; ***P < 0.001; and ****P < 0.0001).